sr 95531 has been researched along with n-(2-aminoethyl)-5-isoquinolinesulfonamide in 1 studies
Studies (sr 95531) | Trials (sr 95531) | Recent Studies (post-2010) (sr 95531) | Studies (n-(2-aminoethyl)-5-isoquinolinesulfonamide) | Trials (n-(2-aminoethyl)-5-isoquinolinesulfonamide) | Recent Studies (post-2010) (n-(2-aminoethyl)-5-isoquinolinesulfonamide) |
---|---|---|---|---|---|
610 | 0 | 209 | 41 | 0 | 8 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kernig, K; Kirschstein, T; Köhling, R; Rohde, M; Würdemann, T | 1 |
1 other study(ies) available for sr 95531 and n-(2-aminoethyl)-5-isoquinolinesulfonamide
Article | Year |
---|---|
The afterhyperpolarizing potential following a train of action potentials is suppressed in an acute epilepsy model in the rat Cornu Ammonis 1 area.
Topics: 2-Amino-5-phosphonovalerate; 6-Cyano-7-nitroquinoxaline-2,3-dione; Action Potentials; Animals; CA1 Region, Hippocampal; Disease Models, Animal; Drug Interactions; Electric Stimulation; Enzyme Inhibitors; Epilepsy; Excitatory Amino Acid Antagonists; GABA Antagonists; In Vitro Techniques; Isoquinolines; Male; Neural Inhibition; Neurons; Pyridazines; Rats; Rats, Wistar; Statistics, Nonparametric; Sulfonamides; Time Factors | 2012 |